A unique lactobacilli collection with genetic capacity to produce natural yellow pigments, carotenoids, and riboflavin for food and beverage applications. These food-grade strains offer health-promoting antioxidant and vitamin benefits, and can simultaneously ferment fruits and vegetables while producing natural antimicrobials, enabling clean-label alternatives to synthetic additives.
This solution leverages a unique collection of more than 1,000 lactobacilli strains with the genetic and functional capacity to produce natural yellow pigments, carotenoids, and riboflavin. Many of these strains are already recognized as food-grade or appear on the European QPS (Qualified Presumption of Safety) list, making them suitable for food and beverage applications. Beyond pigment production, these strains can ferment fruits and vegetables while generating natural antimicrobials, offering a multifunctional ingredient platform for the food industry. The technology addresses growing consumer demand for clean-label, naturally derived colorants and vitamins as alternatives to synthetic food additives.
The technology is currently at an early-to-mid stage of development. Carotenoid and riboflavin production capabilities have been validated using established analytical methods including HPLC-Q-TOF MS and fluorescence assays. Genetic screening of more than 1,000 strains for the crtMN genes has been completed. Future work plans include screening the in-house collection for yellow coloring, genome sequencing of the most promising isolates, chromatographic confirmation of pigment production for the top 20 strains, and fermentation trials using strawberry juices and carrots with a minimum of 10 selected strains. These validation steps will advance the technology toward practical application in juice production and food fermentation.
University of Antwerp is a comprehensive public research university in Flanders with a strong international orientation. Industry collaboration is enabled by co-located laboratories and shared prototyping facilities, an integrated university hospital for clinical translation, and a research and technology park that hosts startups alongside corporate R&D. Its urban campus sits minutes from the Port of Antwerp-Bruges, giving partners access to one of Europe’s largest chemical and logistics clusters and a dense supplier base. Research is supported by competitive funding from the European Union and national and regional agencies. A dedicated technology transfer office supports IP management, licensing, and spin‑out formation, and connects companies with faculty expertise and facilities.